Expert Pitch
Rutgers University-New Brunswick

Rutgers Expert Discusses How COVID-19 Causes Strokes in Otherwise Healthy Adults

7-May-2020 1:20 PM EDT, by Rutgers University-New Brunswick

Physicians treating COVID-19 patients have noted an increase in strokes among young and healthy adults who later are diagnosed or recovering from the disease.

Priyank Khandelwal, an endovascular and vascular neurologist and assistant professor at the Rutgers New Jersey Medical School, discusses why these strokes are increasingly occurring in younger patients and the precautionary measures that can help save their lives.

What is a stroke, and how does it occur?

Acute ischemic stroke, as it is medically called, occurs when there is a sudden blockage or reduction of blood supply to the brain tissue. 

There are two types, small vessel and large vessel strokes. Small vessel strokes are more common and occur when smaller arteries which carry blood get blocked in the brain. Large vessel strokes, affecting larger arteries in the brain, represent about 20 percent of all reported strokes but the majority of stroke-related deaths.

What are the normal risk factors for a stroke? 

Large vessel strokes commonly happen in the elderly population, usually with a median age of 74 years. The presence of high blood pressure, diabetes, high cholesterol, smoking, abnormal rhythm of the heart, and advanced age are some of the common factors which put one at risk for a stroke. 

Why are healthy young, median-aged adults increasingly getting strokes due to COVID-19?

Initial reports from China and New York State have shown blockage of large arteries in the brains of young patients suffering from COVID-19. One hypothesis is that the SARS-CoV-2 virus, which causes COVID-19, induces inflammation, which then causes the thickening of the blood and can result in a severe type of stroke in otherwise healthy young adults. 

Rutgers has created an international registry to characterize strokes from major hotspot regions of the world, including northern New Jersey, and our initial analysis suggests a similar trend. A current study is under review by a medical journal to further investigate the data. 

What are the signs of a stroke?

Signs of a stroke can include sudden numbness in one part of the body or loss of function in one part of the body such as the face, leg or arm; other acute symptoms may include slurred speech, vision problems, trouble walking, dizziness, lack of balance or coordination and intense headache.

What should people do if they suspect they or their loved one is having a stroke – especially considering the concerns of overburdened hospitals and the risks associated with a visit?

Patients should be assured that most hospitals have a robust protocol to take care of them efficiently and safely, even amid the COVID-19 pandemic. Rapid testing is available at certain hospitals where every patient presenting signs of stroke is tested for COVID-19. Results are usually available within two hours, and patients kept in COVID-19 or non-COVID-19 designated stations. 

Patients should therefore seek immediate attention if they or their loved one experiences a sudden onset of blurred or double vision, facial droop, arm and leg weakness, slurred speech or trouble in understanding what others are saying. 

Treatment of stroke either via clot bursting medication or in combination with a catheter-based treatment (mechanical thrombectomy), can only be offered to patients if they reach the hospital in a timely fashion. A delay of even a few hours can result in permanent disability.  

Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.

Showing results

110 of 2539